Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SONIC FOUNDR | SOFO | 4.40% |
| SUPPORTCOM I | SPRT | 3.75% |
| UNISYS CORP | UIS | 3.31% |
| SHORETEL INC | SHOR | 3.22% |
| GREEN MOUNTA | GMCR | 3.13% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Earlier this week, Tenet Healthcare Corporation (THC - Analyst Report) completed the previously-announced private offering of senior notes. Consequently, the company issued $850 million worth of 4.5% senior secured notes, scheduled to mature in 2021.
Tenet Healthcare will use the amount raised to repurchase its outstanding 10% senior secured notes due 2018. Residual proceeds will be used by the company to buy back other outstanding senior secured notes, repay debts and drawings made under the senior secured credit facility, acquisition and for other corporate expenses.
Tenet Healthcare announced a tender offer for the repurchase of the 10% senior secured notes in January and received valid tenders for $644.5 million worth of notes till the consent payment deadline on Feb 4, 2013. Holders of these notes will receive the principal amount along with accrued and unpaid interest and a consent payment of $30 per share. This amounts to a receipt of $1164.50 for every $1000 principal amount held.
Holders of the 10% senior notes who submit a valid tender after the consent payment ate but prior to the expiry of the tender offer will not receive the consent payment. As a result, they will receive only $1134.50 for every $1000 principal amount held. The final settlement for the tender offer is expected on Feb 20, 2013.
The new issuance would require Tenet Healthcare to pay an annual interest of $38.3 million. Nevertheless, the company’s solid operational performance generates enough funds to service the debt uninterruptedly. Its interest expense in the third quarter shot up 74.6% year over year.
Tenet Healthcare is expected to release its fourth-quarter and full year 2012 earnings results on Feb 25. The company currently carries a Zacks Rank #2 (Buy).
Other healthcare service companies like Acadia Healthcare Company, Inc. (ACHC - Snapshot Report) – Zacks Rank #1 (Strong Buy) – and Coventry Health Care Inc. (CVH) and Molina Inc. (MOH - Analyst Report) – Zacks Rank #2 (Buy) – are worth considering.
Get the full Analyst Report on THC - FREE
Get the full Snapshot Report on ACHC - FREE
Get the full Analyst Report on MOH - FREE